To dreambirdie re: NAC
Hi, dreambirdie.
I think that how a PWC will react to NAC while on treatment involving B12 and active folate will depend on their genomic inheritance, on their body's ability to process sulfur-containing substances, and on their mercury body burden.
As I've posted in the past with respect to what freddd has posted about his own case, I think that his genomic situation is somewhat different from that of most people who have CFS, in that it appears that his cells do not have normally functioning B12 processsing enzymes. I think this is why he does not receive benefit from taking hydroxocobalamin, and also why he experiences problems if he takes glutathione or its precursors. NAC can act as a precursor for glutathione synthesis, because it supplies cysteine, which is usually the rate-limiting amino acid for the synthesis of glutathione.
Normally, the cells are able to use any form of B12 and to convert it to the two active coenzyme forms it needs to carry on its normal metabolism. Freddd has found that he needs to take the two coenzyme forms of B12 directly, in fairly large dosages, and on a continuous basis. I think that what he is doing in this way is overcoming his cells' inability to process B12 normally, and supplying the final forms of B12 that they need directly. It is very fortunate for him and that he has found this solution, and it is also very fortunate that the cells are able to respond to the active forms of B12 supplied in this way. There is a small amount of discussion in the published medical literature about this type of treatment in others who have these genomic issues.
I think that the reason freddd does not do well if he takes glutathione or its precursors is that (as he has suggested) the glutathione binds the B12 to form glutathionylcobalamin. This is a normal reaction in the body, and normally it is beneficial, because it protects the B12 in the cells from reacting with other substances in the process of converting it to the two active forms. However, in freddd's case, apparently because he has genomic issues with his processing enzymes, his cells are not able to convert glutathionylcobalamin to the active coenzyme forms of B12, and thus the B12 becomes trapped in a form that his cells cannot use. This intolerance of glutathione provides an important clue that at least part of freddd's genomic issues are downstream of glutathionylcobalamin in the normal B12 metabolism.
For people who do not have these genomic issues, this will not be a problem. Hydroxocobalamin will work alright for them, and glutathione will not block their use of B12. However, as freddd has pointed out, if a person has a serious lack of methyl groups, the cells will have difficulty converting other forms of B12 to methylcobalamin. Dr. Amy Yasko has recognized this in her treatment program, and for some genomic situations, she recommends use of methylcobalamin rather than hydroxocobalamin. She also includes a small amount of TMG in her multi, which will encourage the alternative BHMT pathway in the methylation cycle, thus forming SAMe to supply methyl groups. In my suggestion of the Simplified Treatment Approach, I stayed with hydroxocobalamin to avoid any possible problems with reaction with mercury to form methylmercury. It's possible that I was overly cautious in doing so, as freddd has argued, but I try to err on the side of caution. I note that some of the people who started out with the Simplified Treatment Approach have subsequently switched to methylcobalamin, and at least one has reported benefit from doing so.
Another possible problem with taking NAC is that it will increase the load of sulfur metabolites, and thus increase the flow through the sulfite oxidase enzyme, to form sulfate, which is one of the excretion forms of sulfur in the urine. Some people have a backlog at that point in the pathway, either because of genomic issues with this enzyme, or because of a lack of enough molybdenum, which forms a cofactor for this enzyme, or because they have a significant population of sulfate-reducing bacteria in their gut, which are producing hydrogen sulfide, which also ends up loading the sulfite oxidase enzyme. If these problems are not present, this will not be an issue.
The final possible problem with NAC is that it has been found by Aposhian et al. in rats to be able to transport mercury into the brain. For people who have a significant body burden of mercury, this can be bad news. Dr. David Quig has recommended that the NAC dosage be no greater than 300 mg per day if there is believed to be a significant body burden of toxic heavy metals.
Dr. Cheney has spoken of two cases in which PWCs took large dosages of NAC and subsequently committed suicide. This is anecdotal, and the following is unproven, but it may be that they moved a lot of mercury into the brain.
You mentioned that NAC appears to rescue you from what you think is mobilization of mercury. I think this is possible. Some of the NAC will be converted into glutathione, and glutathione is what the body normally uses to conjugate mercury so that it can be excreted.
I'm glad to hear that NAC helps you, and I think it means that you probably don't have any of the issues I've discussed here. We are dealing with a very heterogeneous population in CFS, so that different people have different responses to things. I try to be careful not to claim that one size fits all. The more cases I study, the more variations I see. I think it's fortunate that a B12-folate type of treatment helps as many people as it does.
Sorry I didn't get to your question earlier.
Best regards,
Rich